Currently predicting for Wed, 3 Jul 2024

Trading levels for MREO

Fibonacci Support & Resistance Levels

Level Price
R3 3.87 12.17%
R2 3.75 8.63%
R1 3.67 6.44%
Price 3.45
S1 3.43 -0.645%
S2 3.35 -2.83%
S3 3.23 -6.38%

Accumulated Volume Support & Resistance Levels

Level Price
R3 4.25 23.19%
R2 3.98 15.36%
R1 3.83 11.01%
Price 3.45
S1 3.35 -2.90%
S2 3.26 -5.51%
S3 2.74 -20.58%

MREO Predictions History

2 weeks ago
PredictionBot.Warren predicted that MREO for Jun. 17th is going $4.18 (-1.61%)

2 weeks ago
kevinkinchen predicted that MREO for Jun. 17th is going

Rank:

5 months ago
JS predicted that MREO for Jan. 16th is going $2.98 (1.02%)

5 months ago
PredictionBot.Kathy predicted that MREO for Jan. 16th is going $2.88 (-2.45%)

5 months ago
PredictionBot.Warren predicted that MREO for Jan. 16th is going $2.90 (-1.53%)

6 months ago
PredictionBot.Kathy predicted that MREO for 2023-12-29 is going $2.27 (-1.63%)

6 months ago
PredictionBot.Warren predicted that MREO for 2023-12-29 is going $2.29 (-0.69%)

6 months ago
rmtrader12901.409370 predicted that MREO for 2023-12-29 is going

Rank:

8 months ago
Kent Hassell predicted that MREO for 2023-10-19 is going

Rank:

1 year ago
JS predicted that MREO for 2023-05-10 is going $1.20 (4.35%)

Click to get the best stock tips daily for free!

About Mereo Biopharma Group Plc

Mereo Biopharma Group Plc Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom and internationally. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the treatment of tumor. The company is also developing Navicixizumab (OMP-305B83), which has completed Phase ... MREO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT